Concepedia

Samer O. Abdul‐Hay

SO

19

Publications

785

Citations

16

H-Index

2008

Active since

Affiliations

Mayo Clinic in Florida(Current)

University of Illinois Chicago

Jacksonville College

University of California, Irvine

Boston University

Samer O. Abdul‐Hay is an author at Mayo Clinic in Florida specializing in medicine, pharmacology, and drug discovery.

Top concepts

Publications per year

2008–2024

19

Publications

19

Deletion of Insulin-Degrading Enzyme Elicits Antipodal, Age-Dependent Effects on Glucose and Insulin Tolerance

Samer O. Abdul‐Hay, Dongcheul Kang, Melinda McBride et al. · PLoS ONE · 2011 · 117 citations · Full text

Designed Inhibitors of Insulin-Degrading Enzyme Regulate the Catabolism and Activity of Insulin

Malcolm A. Leissring, E. Malito, Sabrine Hédouin et al. · PLoS ONE · 2010 · 106 citations · Full text

ApoE variant p.V236E is associated with markedly reduced risk of Alzheimer’s disease

Christopher W Medway, Samer O. Abdul‐Hay, Tynickwa Mims et al. · Molecular Neurodegeneration · 2014 · 81 citations · Full text

Cathepsin D regulates cerebral Aβ42/40 ratios via differential degradation of Aβ42 and Aβ40

Caitlin N. Suire, Samer O. Abdul‐Hay, Tomoko Sahara et al. · Alzheimer s Research & Therapy · 2020 · 74 citations · Full text

Identification of BACE2 as an avid ß-amyloid-degrading protease

Samer O. Abdul‐Hay, Tomoko Sahara, Melinda McBride et al. · Molecular Neurodegeneration · 2012 · 64 citations · Full text

Rows per page

1–5 of 19